Abstract
To evaluate the association of plasma osteoprotegerin (OPG) to hospitalisation for ischaemic heart disease (IHD), ischaemic stroke and all-cause mortality, and the effect of combining plasma OPG and high-sensitivity C-reactive protein (hsCRP).
| Originalsprog | Engelsk |
|---|---|
| Tidsskrift | Heart |
| Vol/bind | 99 |
| Udgave nummer | 2 |
| Sider (fra-til) | 106-10 |
| Antal sider | 5 |
| ISSN | 1355-6037 |
| DOI | |
| Status | Udgivet - 2013 |